These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7289451)

  • 1. [Evaluation of urate homeostasis in chronic glomerulonephritis].
    Burian AE
    Klin Med (Mosk); 1980 Jul; 58(7):100-4. PubMed ID: 7289451
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indicators of trioxipurine metabolism in healthy persons and in patients with acute diffuse glomerulonephritis].
    Eĭl'bart VL
    Ter Arkh; 1980; 52(4):73-5. PubMed ID: 7404345
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in the correlation between free amino acid levels in the saliva and blood plasma in chronic glomerulonephritis].
    Nikula TD
    Vrach Delo; 1981 Jul; (7):14-7. PubMed ID: 7281605
    [No Abstract]   [Full Text] [Related]  

  • 4. Does Tamm-Horsfall protein-uric acid binding play a significant role in urate homeostasis?
    Gersch MS; Sautin YY; Gersch CM; Henderson G; Bankir L; Johnson RJ
    Nephrol Dial Transplant; 2006 Oct; 21(10):2938-42. PubMed ID: 16861244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urate metabolism in sarcoidosis.
    Goldstein RA; Becker KL; Israel HL; Moore CF
    Arch Intern Med; 1974 Mar; 133(3):379-81. PubMed ID: 4283738
    [No Abstract]   [Full Text] [Related]  

  • 6. [State of lipid metabolism in acute and chronic diffuse glomerulonephritis].
    Alekseev GI; Storozhenko AA
    Klin Med (Mosk); 1974 Jan; 52(1):70-4. PubMed ID: 4466890
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of acute urate nephropathy].
    Engelhardt R; von der Thann M; Löhr GW
    Med Welt; 1980 Oct; 31(40):1450-4. PubMed ID: 7464501
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies of the water-electrolyte composition of the body in chronic glomerulonephritis measured with the aid of Na22 and Br82 and of 4-amino-antipyrine].
    Romagnoli GF; Mendola R; Borsatti A; Bertaglia G; Barbui T; Mioni G; Huber W
    Minerva Nefrol; 1968; 15(4):290-6. PubMed ID: 5747375
    [No Abstract]   [Full Text] [Related]  

  • 9. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.
    Myllymäki J; Honkanen T; Syrjänen J; Helin H; Rantala I; Pasternack A; Mustonen J
    Nephrol Dial Transplant; 2005 Jan; 20(1):89-95. PubMed ID: 15572382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of water-salt metabolic indices in chronic glomerulonephritis patients being treated with dry heat].
    Sidorova LD; Trofimova ER; Ierusalimskaia LA; Benin IuL
    Vopr Kurortol Fizioter Lech Fiz Kult; 1984; (1):43-5. PubMed ID: 6710917
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of galascorbin on glycoprotein metabolism in chronic glomerulonephritis].
    Kushnereva AG; Pedan VT; Katushkov IuF
    Vrach Delo; 1976 Jun; (6):58-60. PubMed ID: 969461
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute urate nephropathy in perimenopausal women].
    Solov'eva OA; Balkarov IM; Miroshnichenko NG; Kireeva VI
    Ter Arkh; 2006; 78(10):61-4. PubMed ID: 17180941
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of disorders of metabolism of carbohydrate-protein compounds in diffuse kidney diseases].
    Bakhtadze GG; Anasashvili ATs
    Ter Arkh; 1976; 48(7):23-9. PubMed ID: 996743
    [No Abstract]   [Full Text] [Related]  

  • 14. [Uric acid metabolism in patients with liver disease (author's transl)].
    Higuchi T; Nakamura T; Uchino H
    Ryumachi; 1980 Nov; 20(5):344-9. PubMed ID: 7345653
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M; Freel RW; Shahinfar S; Vaziri ND
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic identification of potential phospholipid biomarkers for chronic glomerulonephritis by using high performance liquid chromatography-mass spectrometry.
    Jia L; Wang C; Zhao S; Lu X; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(1):134-40. PubMed ID: 17996503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of clinical forms and the course of chronic glomerulonephritis].
    Stavskaia VV; Bondarenko BB; Zhdanova LD; Bogorodskaia TA; Minkin RB
    Klin Med (Mosk); 1973 Jan; 51(1):55-60. PubMed ID: 4764842
    [No Abstract]   [Full Text] [Related]  

  • 18. Uric Acid and renal disease.
    Cameron JS
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1055-64. PubMed ID: 17065064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal urate transport.
    Mount DB; Kwon CY; Zandi-Nejad K
    Rheum Dis Clin North Am; 2006 May; 32(2):313-31, vi. PubMed ID: 16716882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The interaction of atrial natriuretic peptide with other bioregulators of kidney function in chronic glomerulonephritis in children].
    Kucherenko AG; Markov KhM; Zokirov NZ; Naumova VI
    Urol Nefrol (Mosk); 1994; (2):45-8. PubMed ID: 8017007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.